Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVE: High-dose Atorvastatin Post-CABG
NCT01528709Phase 3Completed
- Sponsor
- Boca Raton Regional Hospital
- Start
- Mar 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of atorvastatin in saphenous vein graft disease (SVGD), sponsored by Boca Raton Regional Hospital. Started Mar 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
saphenous vein graft disease (SVGD)
Beyond the preview
Go deeper on NCT01528709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528709.